Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhIL-12 for Relapsed Lymphoma and Hodgkin's Disease
NCT00003210Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Feb 1998
- Primary completion
- Nov 2003
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of recombinant interleukin-12 in non-Hodgkin lymphoma (NHL), Hodgkin lymphoma (HL), sponsored by National Cancer Institute. Started Feb 1998; status: completed.
02
Drugs
recombinant interleukin-12
03
Conditions
non-Hodgkin lymphoma (NHL)Hodgkin lymphoma (HL)
Beyond the preview
Go deeper on NCT00003210.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003210.